This inventor holds 2 USPTO granted patents. Top assignees: Polychip Pharmaceuticals Pty Ltd., The University of Sydney, Other. Active years: 2003-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 7 
1 out of 275 
1 out of 834,513 Years Active: 2003-2005
Title: Graham A R Johnston: Innovator in Neurologically-Active Compounds
Introduction
Graham A R Johnston is a notable inventor based in Roseville, Australia. He has made significant contributions to the field of neurologically-active compounds, focusing on enhancing cognitive activity and memory capacity in animals. With a total of 2 patents, his work has implications for treating cognitive deficits and memory impairments.
Latest Patents
Johnston's latest patents revolve around the development of compounds that act as selective GABA receptor antagonists. The first patent describes compounds of a specific formula, where R can represent various alkyl groups, including propyl, butyl, pentyl, neo-pentyl, or cyclohexyl, along with their salts. This invention provides methods for enhancing cognitive activity and stimulating memory capacity in animals by administering effective amounts of these compounds. The second patent further elaborates on methods for treating conditions such as dementias and cognitive deficits, emphasizing the importance of compounds with GABA receptor antagonist activity.
Career Highlights
Throughout his career, Johnston has worked with reputable organizations, including the University of Sydney Commercial Development & Industry Partnerships and Polychip Pharmaceuticals Pty Ltd. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative solutions in the field of neuroscience.
Collaborations
Johnston has collaborated with esteemed colleagues, including Mary Chebib and Jane Hanrahan. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Graham A R Johnston's contributions to the field of neurologically-active compounds highlight his innovative spirit and dedication to improving cognitive health. His patents and collaborations reflect a commitment to advancing scientific knowledge and developing effective treatments for cognitive impairments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile